Navigation Links
If You Bought ExtenZe, You Might Receive Money and Benefits from a Class Action Settlement.
Date:10/27/2010

SANTA MONICA, Calif., Oct. 27 /PRNewswire/ -- The following statement is being issued by Milstein, Adelman & Kreger, LLP and Wasserman, Comden, Casselman & Esensten, LLP regarding the ExtenZe class action settlement.

A proposed class action settlement has been reached involving the manufacturer of a male enhancement product called ExtenZe.  The case is known as Williams, et al. v. Biotab Nutraceuticals, Inc., et al., Case No. BC414808 (consolidated with BC415918) ("the Action") Los Angeles County Superior Court.  The lawsuit alleges that Biotab Nutraceuticals, Inc. ("Biotab"), the manufacturer of ExtenZe, and certain individuals made false claims in certain marketing, promotional and advertising materials saying that ExtenZe would increase penis size.  Biotab and the other defendants deny they did anything wrong.

Who is a Class Member?  The Class consists of all persons who purchased ExtenZe in the United States between May 29, 2005 and October 25, 2010.  

What is this case about? If the settlement is approved, Defendants will be enjoined from making certain representations about their product, including being prevented from claiming that it will make the penis larger absent independent scientific substantiation. Further, a cash fund of $6,000,000 will be set up along with an additional $6,000,000 in retail value of ExtenZe NASCAR merchandise. A full description of the benefits can be found on www.extenzesettlement.com. Class Members who submit a valid Claim Form may choose a refund on the previously purchased product or choose up to $176.94 worth of ExtenZe NASCAR racing apparel. Full details of all the benefits are found on www.extenzesettlement.com.

What are my options?  You have decisions to make and you must make them now.  Stay in the class. In order to receive a cash reimbursement or racing apparel, you must obtain and submit a valid Claim Form. Claim Forms can be obtained by calling the 800 number or visiting www.extenzesettlement.com. The deadline to file your claim is April 15, 2011. If you stay in the class, you give up any rights to sue Defendants about the same legal claims in this lawsuit and you will be bound by the Court's decisions. The Claim Form will include instructions for the submission process.  Settlement Class Members may submit Claim Forms online, or by mail to the Settlement Administrator at the address below.

Get out of the lawsuit.  If you ask to be excluded, you will NOT receive money or benefits if the Settlement is approved, but you keep any rights to sue Defendants separately about the same legal claims in this lawsuit.  If you intend to bring your own lawsuit against Defendants, you should exclude yourself from the Class.  If you want to exclude yourself from the class action, you must formally request to exclude yourself by sending a letter to: Williams, et al. v. Biotab Nutraceuticals, Inc. EXCLUSIONS: c/o The Garden City Group, Inc., P.O. Box 9478, Dublin, OH 43017-4578.  You must sign and date the letter, which must be postmarked on or before January 11, 2011.

Who represents you?  As a member of the Class, you will be represented by Wasserman, Comden, Casselman & Esensten, LLP, 5567 Rededa Blvd., Ste. 330, Tarzana CA 91357-7033; Milstein Adelman & Kreger, LLP, 2800 Donald Douglas Loop North, Santa Monica, CA 90405; the Law Office of Bruce B. Whitman; Statman, Harris & Eyrich, LLC; and the Newport Trial Group, LLC. You will not be charged a fee for their services in this case.  However, if you want to be represented by your own lawyer, you may hire one at your own expense.

The Court will hold a Final Approval Hearing on March 30, 2011 in Department 28 of Los Angeles County Superior Court to consider the Settlement and Class Counsel's request for attorneys' fees, plus expenses.  You don't have to attend the Hearing.  

For more information.  This notice is only a summary.  For more detailed information, please call 800-961-6428, visit www.extenzesettlement.com, or write to Williams, et al. v. Biotab Nutraceuticals, Inc: c/o The Garden City Group, Inc. P.O. Box 9478 Dublin, OH 43017-4578.


'/>"/>
SOURCE Wasserman, Comden, Casselman & Esensten, LLP and Milstein, Adelman & Kreger, LLP
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Most Women With HIV and Their Health Care Providers Have Not Discussed How HIV Might Affect Them Differently Than Men
2. St. Jude Study Finds Treatment With New Drug Might Make Tumor Cells More Sensitive to Therapy
3. Aching Back? Cholesterol Medication Might Help
4. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
5. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
8. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
9. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
10. CryoCor Receives FDA Approval for Right Atrial Flutter
11. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Calif. , June 24, 2016  Global ... a biopharmaceutical company developing novel therapeutics for the ... needs, today announced the closing of its previously ... common stock, at the public offering price of ... the offering were offered by GBT. GBT estimates ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... 2016 According to a new ... Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, ... Mode of Purchase (Retail, Non-Retail) - Trends & Global ... the market for the forecast period of 2016 to ... Billion by 2021 from USD 1.65 Billion in 2016, ...
Breaking Medicine Technology:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and ... their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took ... the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
Breaking Medicine News(10 mins):